eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2021, Volume 17, Issue 2 : 26-30
Research Article
PCI Safety in Elderly Patients Above 75 Years
 ,
 ,
1
Department of Interventional Cardiology, Apollo Heart Institute, Kolkata, India
2
Cardiovascular Research Unit, Mount Sinai Medical Center, New York, USA
3
Department of Geriatric Cardiology, Northeast Medical College & Research Centre, Assam, India
Received
Aug. 18, 2021
Revised
Sept. 29, 2021
Accepted
Nov. 11, 2021
Published
Dec. 21, 2021
Abstract

Percutaneous coronary intervention (PCI) is a key treatment modality for acute and chronic coronary syndromes. However, clinical decision-making becomes significantly complex in elderly patients aged above 75 due to frailty, multiple co-morbidities, cognitive impairment, high bleeding risk, vascular calcification, and reduced physiological reserve. This study evaluates safety profiles, mortality rates, procedural risks, and outcome predictors in elderly patients undergoing PCI. A retrospective cohort of 412 elderly patients (≥75 years) was analyzed over five years across tertiary cardiac centers. Findings indicate higher in-hospital mortality (5.6%) and increased vascular complications (11.3%) compared to younger cohorts (≤65 years: 2.1% and 3.4% respectively). However, when performed with radial access, optimal antithrombotic strategies, and minimal contrast use, PCI demonstrated favorable survival and symptom improvement. The study concludes that PCI remains safe but requires geriatric-adaptive protocols.

 

 

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.